INM - InMed Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $56.98. This is a potential upside of $54.63 (2324.68%) from yesterday's end of day stock price of $2.35.

InMed Pharmaceuticals's activity chart (see below) currently has 1 price targets and 1 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Dec-2021. First documented stock forecast 01-Dec-2021.

Raghuram Selvaraju Scott Henry

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$150

$149.41 (25323.73%)

3 years 5 months 10 days ago
(01-Dec-2021)

0/1 (0%)

$109.25 (268.10%)

0/1 (0%)

Show more analysts

What is INM (InMed Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on INM (InMed Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on INM (InMed Pharmaceuticals) with a proven track record?

SCOTT HENRY

Which analyst has the most public recommendations on INM (InMed Pharmaceuticals)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 3 price targets and 16 ratings on INM

Which analyst is the currently most bullish on INM (InMed Pharmaceuticals)?

Raghuram Selvaraju with highest potential upside - $149.41

Which analyst is the currently most reserved on INM (InMed Pharmaceuticals)?

Scott Henry with lowest potential downside - -$0